← Back to Search

Cognitive Behavioral Therapy for Suicide Attempt

N/A
Waitlist Available
Led By David F Tolin, Ph.D.
Research Sponsored by Hartford Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed on a monthly basis for 6 months follow-up.
Awards & highlights

Study Summary

This trial will compare the efficacy of cognitive behavioral therapy to treatment as usual for inpatient suicide prevention.

Eligible Conditions
  • Attempted Suicide

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at baseline, at completion of inpatient treatment (average of 16 days), and on a monthly basis for 6 months follow-up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at baseline, at completion of inpatient treatment (average of 16 days), and on a monthly basis for 6 months follow-up. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Number of Readmissions
Change in Suicidal Behavior
Change in Suicidal Ideation/Intent

Side effects data

From 2021 Phase 4 trial • 12 Patients • NCT04135937
8%
irritability
100%
80%
60%
40%
20%
0%
Study treatment Arm
MESH

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Presence of SUD with BCBTExperimental Treatment1 Intervention
Patients diagnosed with SUD who are randomly assigned to receive BCBT will participate in all aspects of their prescribed treatment plan (i.e., TAU) and will receive up to 4 sessions of CBT (depending on length of stay), lasting 1.5 hours for the first session and 1 hour for the remaining sessions.
Group II: Absence of SUD with BCBTExperimental Treatment1 Intervention
Patients without SUD who are randomly assigned to receive BCBT will participate in all aspects of their prescribed treatment plan (i.e., TAU) and will receive up to 4 sessions of BCBT (depending on length of stay), lasting 1.5 hours for the first session and 1 hour for the remaining sessions.
Group III: Absence of SUD with TAUActive Control1 Intervention
Patients without SUD who are randomly assigned to receive TAU will participate in all aspects of the prescribed treatment plan given by the inpatient unit.
Group IV: Presence of SUD with TAUActive Control1 Intervention
Patients diagnosed with SUD who are randomly assigned to receive TAU will participate in all aspects of the prescribed treatment plan given by the inpatient unit.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Behavioral Therapy
2016
Completed Phase 4
~3120

Find a Location

Who is running the clinical trial?

American Foundation for Suicide PreventionOTHER
33 Previous Clinical Trials
9,562 Total Patients Enrolled
Hartford HospitalLead Sponsor
133 Previous Clinical Trials
18,719 Total Patients Enrolled
David F Tolin, Ph.D.Principal InvestigatorInstitute of Living/Hartford Hospital
2 Previous Clinical Trials
136 Total Patients Enrolled
~40 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top